FDA advisory committee: Panel sees class III for CES, doc says vets need treatment Feb. 14, 2012 By Mark McCarty
Report from Europe: DiaGenic making progress on blood-based Parkinson's test Feb. 14, 2012 By Cormac Sheridan
Deals roundup: SeraCare to be acquired by Linden, valued at $82 million Feb. 14, 2012 By Robert Kimball
RSS